Study provides valuable insights into the DCB-only strategy for left main coronary artery disease

News Medical

Center

Mixed Factuality

Other: Ian Birkby

Study provides valuable insights into the DCB-only strategy for left main coronary artery disease

Sanna Uskela et al., at North Karelia Central Hospital-Heart Center, Finland, conducted a retrospective single-center registry study that focused on the use of drug-coated balloon (DCB)-only strategy for treating de novo left main coronary artery disease.